FDA Issues an Ongoing Safety Review of Cefepime

Jamie Sheller

Attorney
(866) 735-1102 Ext 475

0 CommentsPrint ArticleSubscribe

Cefepime, marketed as Maxipime, is manufactured by Bristol Meyers Squibb. A recent study of this drug has raised concerns about the increased mortality rate associated with its use. Based on this study, the FDA has begun a safety review which will not be completed for another four months. Cefepine or Maxipine is an antibioltic used for patients who have infections of the ear, chest, skin, bones, bladder of gonorrhea. For more information check the FDA website at: http://www.fda.gov/cder/drug/early_comm/cefepime.htm

For more information on this subject, please see our section on Drugs, Medical Devices and Implants.